Bristol Myers Squibb Reports Third Quarter Financial Results for 2026 and Raises Full-Year Revenue Outlook
Revenue$13.1 billion+7% YoY
EPS$1.05
Outlookraisedguidance
Details · Original release on SEC.gov ↗ · Our research on BMY →